Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	88407
Country	China

Received	2023-09-23 13:40
Peer-Review Started	2023-09-23 13:42
To Make the First Decision
Return for Revision	2023-12-26 04:59
Revised	2023-12-28 08:32
Second Decision	2024-01-19 02:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-01-19 05:36
Articles in Press	2024-01-19 05:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-26 08:27
Publish the Manuscript Online	2024-02-02 09:42

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Cardiotoxicity induced by fluoropyrimidine drugs in the treatment of gastrointestinal tumors
Manuscript Source	Invited Manuscript
All Author List	Mo-Wei Kong, Feng-Di Sun, Zhen-Ying Pei, Li Xu, Ze-Bi Wang, Yan Chen, Shu-Qing Tang, Ting-Fang Yang and Guo-Xiang He
Funding Agency and Grant Number
Corresponding Author	Ting-Fang Yang, MD, Doctor, Department of Oncology, Guiqian International General Hospital, No. 1 Dongfeng Avenue, Wudang, Guiyang 550018, Guizhou Province, China. 672539517@qq.com
Key Words	Cardiotoxicity; Gastrointestinal tumors; Risk factors; Fluoropyrimidine; Chest pain
Core Tip	This editorial focuses on the occurrence, clinical characteristics, and risk factors of fluoropyrimidine drug-related cardiotoxicity in patients with gastrointestinal tumors. Despite advancements in diagnostic and therapeutic techniques for digestive system tumors, treatment-related cardiotoxicity rates have been increasing, impacting the survival and prognosis of cancer patients. Fluoropyrimidine drugs, widely used in treating malignant tumors, including gastrointestinal tumors, are the second largest class of drugs associated with cardiotoxicity. However, there is often a lack of awareness or understanding regarding their cardiotoxic effects and associated risks.
Publish Date	2024-02-02 09:42
Citation	Kong MW, Sun FD, Pei ZY, Xu L, Wang ZB, Chen Y, Tang SQ, Yang TF, He GX. Cardiotoxicity induced by fluoropyrimidine drugs in the treatment of gastrointestinal tumors. World J Gastrointest Oncol 2024; 16(2): 251-254
URL	https://www.wjgnet.com/1948-5204/full/v16/i2/251.htm
DOI	https://dx.doi.org/10.4251/wjgo.v16.i2.251

Full Article (PDF)	WJGO-16-251-with-cover.pdf
Full Article (Word)	WJGO-16-251.docx
Manuscript File	88407_Auto_Edited-YJP.docx
Answering Reviewers	88407-Answering reviewers.pdf
Audio Core Tip	88407-Audio core tip.wav
Conflict-of-Interest Disclosure Form	88407-Conflict-of-interest statement.pdf
Copyright License Agreement	88407-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	88407-Language certificate.pdf
Peer-review Report	88407-Peer-review(s).pdf
Scientific Misconduct Check	88407-Bing-Li L-2.png
Scientific Editor Work List	88407-Scientific editor work list.pdf